Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis
Standard
Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis. / Ringe, Kristina I; Grigoriadis, Aristeidis; Halibasic, Emina; Wacker, Frank; Manns, Michael P; Schramm, Christoph; Lenzen, Henrike; MRI working group of the IPSCSG.
in: HEPATOLOGY, Jahrgang 69, Nr. 3, 03.2019, S. 1358-1359.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis
AU - Ringe, Kristina I
AU - Grigoriadis, Aristeidis
AU - Halibasic, Emina
AU - Wacker, Frank
AU - Manns, Michael P
AU - Schramm, Christoph
AU - Lenzen, Henrike
AU - MRI working group of the IPSCSG
N1 - Letter
PY - 2019/3
Y1 - 2019/3
N2 - Recently, the MRI working group of the International PSC Study Group (IPSCSG) has published a position statement on the use of MRI regarding diagnosis and follow-up of PSC patients. These guidelines are intended for use by physicians in daily clinical routine. In addition, the group has outlined several areas of research, which need to be addressed in the near future. As PSC is a rare disease with the clinical outcome being determined by the development of end-stage liver disease and hepatobiliary malignancy. This article is protected by copyright. All rights reserved.
AB - Recently, the MRI working group of the International PSC Study Group (IPSCSG) has published a position statement on the use of MRI regarding diagnosis and follow-up of PSC patients. These guidelines are intended for use by physicians in daily clinical routine. In addition, the group has outlined several areas of research, which need to be addressed in the near future. As PSC is a rare disease with the clinical outcome being determined by the development of end-stage liver disease and hepatobiliary malignancy. This article is protected by copyright. All rights reserved.
KW - Letter
U2 - 10.1002/hep.30276
DO - 10.1002/hep.30276
M3 - Other (editorial matter etc.)
C2 - 30222864
VL - 69
SP - 1358
EP - 1359
JO - HEPATOLOGY
JF - HEPATOLOGY
SN - 0270-9139
IS - 3
ER -